AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+4.23%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$12B
AUM Growth
+$538M
(+4.7%)
Cap. Flow
+$267M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
58.6%
Holding
1,163
New
169
Increased
414
Reduced
393
Closed
182
Top Buys
| 1 |
Enterprise Products Partners
EPD
|
$174M |
| 2 |
MPLX
MPLX
|
$163M |
| 3 |
Energy Transfer Partners
ET
|
$131M |
| 4 |
Plains All American Pipeline
PAA
|
$129M |
| 5 |
Western Midstream Partners
WES
|
$105M |
Top Sells
Sector Composition
| 1 | Energy | 67.67% |
| 2 | Technology | 4.7% |
| 3 | Healthcare | 3.47% |
| 4 | Consumer Discretionary | 3.35% |
| 5 | Financials | 3.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Veeva Systems
VEEV
$44.7B
| $305K | ﹤0.01% |
1,499
-431
| -22% | -$87.7K |
|
877
Toll Brothers
TOL
$14.2B
| $304K | ﹤0.01% |
4,116
-1,419
| -26% | -$105K |
|
|
SKE
878
Skeena Resources
SKE
$1.99B
| $304K | ﹤0.01% |
66,564
| – | – |
|
879
Comerica
CMA
$8.85B
| $303K | ﹤0.01% |
7,284
+1,882
| +35% | +$78.2K |
|
880
Amphastar Pharmaceuticals
AMPH
$1.37B
| $302K | ﹤0.01% |
6,566
-2,325
| -26% | -$107K |
|
881
TopBuild
BLD
$12.3B
| $302K | ﹤0.01% |
1,199
-448
| -27% | -$113K |
|
882
M/I Homes
MHO
$4.14B
| $301K | ﹤0.01% |
3,582
-1,888
| -35% | -$159K |
|
|
AUTL
883
Autolus Therapeutics
AUTL
$389M
| $299K | ﹤0.01% |
128,147
+927
| +0.7% | +$2.16K |
|
884
Builders FirstSource
BLDR
$16.5B
| $296K | ﹤0.01% |
2,377
-1,512
| -39% | -$188K |
|
885
Axos Financial
AX
$5.13B
| $296K | ﹤0.01% |
7,815
-620
| -7% | -$23.5K |
|
886
Scholar Rock
SRRK
$3.02B
| $295K | ﹤0.01% |
41,535
+1,628
| +4% | +$11.6K |
|
|
SBOW
887
DELISTED
SilverBow Resources, Inc.
SBOW
| $294K | ﹤0.01% |
+8,230
| New | +$294K |
|
888
Voyager Therapeutics
VYGR
$235M
| $294K | ﹤0.01% |
+37,900
| New | +$294K |
|
889
Medpace
MEDP
$13.7B
| $293K | ﹤0.01% |
1,212
-599
| -33% | -$145K |
|
890
McEwen Inc.
MUX
$734M
| $293K | ﹤0.01% |
45,049
| – | – |
|
|
LAC
891
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $292K | ﹤0.01% |
17,183
+6,004
| +54% | +$102K |
|
892
OceanFirst Financial
OCFC
$1.05B
| $292K | ﹤0.01% |
20,178
+5,008
| +33% | +$72.5K |
|
893
Harmony Biosciences
HRMY
$2.07B
| $291K | ﹤0.01% |
+8,870
| New | +$291K |
|
|
ITOS
894
DELISTED
iTeos Therapeutics
ITOS
| $289K | ﹤0.01% |
26,426
+137
| +0.5% | +$1.5K |
|
895
Aldeyra Therapeutics
ALDX
$334M
| $289K | ﹤0.01% |
43,250
+192
| +0.4% | +$1.28K |
|
896
Mineralys Therapeutics
MLYS
$2.31B
| $287K | ﹤0.01% |
30,148
+117
| +0.4% | +$1.11K |
|
897
Clorox
CLX
$15.5B
| $286K | ﹤0.01% |
2,182
+67
| +3% | +$8.78K |
|
898
Sigma Lithium
SGML
$716M
| $285K | ﹤0.01% |
8,778
+3,104
| +55% | +$101K |
|
899
Assertio
ASRT
$76.8M
| $283K | ﹤0.01% |
110,594
+55,259
| +100% | +$141K |
|
|
JBIO
900
Jade Biosciences, Inc. Common Stock
JBIO
$254M
| $277K | ﹤0.01% |
583
+60
| +11% | +$28.5K |
|